Position in DNLI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$30,603,867
+$9,486,843 QoQ
Shares Held
1,189,886
+8.2% QoQ
Ownership
0.744%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#34
of 290 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Candriam S.C.A. holds $2,107,868,027 across 75 Biotechnology names. DNLI ranks #26 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
195,674 | $122,010,565 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
556,392 | $104,201,093 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
199,505 | $99,100,118 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
314,512 | $94,677,547 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
289,735 | $82,565,782 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
2,088,369 | $80,819,880 | |
| 7 | ARGX |
Argenx SE
|
80,120 | $74,332,932 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,990,510 | $70,444,148 |
All Filings in DNLI
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,603,867 | 1,189,886 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $21,117,024 | 1,099,845 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $19,256,917 | 1,166,379 | Shares | Sole | 2026-04-30 | |
| 2025-09-30 | $12,103,610 | 833,582 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $11,811,043 | 844,249 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $11,666,712 | 858,162 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $16,976,071 | 832,977 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $27,445,062 | 942,158 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $16,869,306 | 726,499 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $9,190,456 | 447,878 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $7,680,061 | 357,878 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,383,023 | 357,878 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $10,560,979 | 357,878 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $8,245,509 | 357,878 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $9,952,587 | 357,878 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $10,983,275 | 357,878 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $9,502,417 | 322,882 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $4,552,280 | 141,507 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,311,212 | 141,507 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,217,751 | 63,781 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $5,002,981 | 63,781 | Shares | Sole | 2021-07-20 | |
| No filing history on record for this holder in this stock. | ||||||